Contemporary measures for the assessment of health-related quality of life in prostate cancer

References

• Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAIVIA 280 (11), 975–980 (1998).Landmark paper describing natural history of and mortality from prostate cancer stratified by tumor grade.
   Google Scholar
• Carter HB, Epstein JI, Partin AW. Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology53(1), 126–130 (1999).
   PubMed Web of Science ®Google Scholar
• Brawley OW Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer80 (9), 1857–1863 (1997).
   PubMed Web of Science ®Google Scholar
• Van Erps P, Van Den Weyngaert D, Denis L. Surgery or radiation: is there really a choice for early prostate cancer. Critical Reviews in Oncol Hematol 27(1), 11–27 (1998).
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE . Quality-of-life outcomes in men treated for localized prostate cancer. JAIVIA 273(2), 129–135 (1995).Landmark paper presenting results of the first large study of prostate cancer HRQOL across treatments using a validated instrument.
   Google Scholar
• Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. Ural 164(6), 1973–1977 (2000).
   PubMed Web of Science ®Google Scholar
• Potosky AL, Legler J, Albertsen PC etalHealth outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J. Natl Cancer Inst. 92(19), 1582–1592 (2000).
   PubMed Web of Science ®Google Scholar
• Schapira MM, Lawrence WF, Katz DA,McAuliffe TL, Nattinger AB. Effect of treatment on quality of life among men with clinically localized prostate cancer. Medical Care 39(3), 243–253 (2001).
   PubMedGoogle Scholar
• Pisters LL, Dinney CP, Pettaway CA et al Afeasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J. Ural 161(2), 509–514 (1999).
   PubMed Web of Science ®Google Scholar
• Turner SL, Gruenewald S, Spry N, Gebski V, Metastron UG. Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. BE J. Cancer84(3), 297–302 (2001).
   Google Scholar
• Koeneman KS, Hsieh JT. The prospect of gene therapy for prostate cancer: update on theory and status. Current Opinion in Ural11(5), 489–494 (2001).
   PubMedGoogle Scholar
• Rini BI, Small EJ. Immunotherapy for prostate cancer. Current Oncol Reports 3(5), 418–423 (2001).
   PubMedGoogle Scholar
• Imperiale MJ, Pass HI, Sanda MG.Prospects for an 5V40 vaccine. Semin. Cancer Biol. 11(1), 81–85 (2001).
   Google Scholar
• Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl. J. Med. 334(13), 835–840 (1996).
   Google Scholar
• Wilson TB, Cleary PD. Linking clinicalvariables with health-related quality of life. A conceptual model of patient outcomes. JAIVIA 273(1), 59–65 (1995).An important paper describing a conceptual framework for linking HRQOL measures to clinical medicine and basic science.
   Google Scholar
• Ware JE, Jr., Brook RII, Davies AR, Lohr KN. Choosing measures of health status for individuals in general populations. Am. J: Public Health 71(6), 620–625 (1981).
   Google Scholar
• Barry MJ. Quality of life and prostate cancer treatment. J: Ural 162(2), 407 (1999).
   PubMed Web of Science ®Google Scholar
• Browne JR Health-related quality-of-life studies in urology: conceptual and methodological considerations. World J. Ural 17(4), 193–198 (1999).
   Web of Science ®Google Scholar
• Litwin MS. Examining health-related quality of life in men treated for prostate cancer. World J. Ural 17(4), 205–210 (1999).
   Web of Science ®Google Scholar
• Macdonagh R. Quality of life and its assessment in urology. BE J: Ural 78(4), 485–496 (1996).
   PubMed Web of Science ®Google Scholar
• McDowell I, Newell C. Measuring- Health. (2nd Edition). Oxford University Press, Inc., New York City, USA (1996).
   Google Scholar
• •Well-written textbook summarizing general HRQOL instruments.
   Google Scholar
• Streiner DL, Norman J. Health Illasurement Scales. (2nd &lido Oxford University Press,Inc., New York, USA (1995).
   Google Scholar
• •Well-written textbook describing the necessary steps for development of novel HRQOL instruments.
   Google Scholar
• Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J: Ural 159(6), 1988–1992 (1998).
   PubMed Web of Science ®Google Scholar
• Knight SJ, Chmiel JS, Sharp LK etalSpouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability and validity. Urology 57(2), 275–280 (2001).
   PubMed Web of Science ®Google Scholar
• Sneeuw KC, Albertsen PC, Aaronson NK.Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer. J: Ural 165(2), 478–482 (2001).
   PubMed Web of Science ®Google Scholar
• Kielb S, Dunn RL, Rashid MG etalAssessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairment. Ural 166(3), 958–961 (2001).
   PubMed Web of Science ®Google Scholar
• Litwin MS, Melmed GY, Nakazon T Lifeafter radical prostatectomy: A longitudinal study.j Ural 166(2), 587–592 (2001).
   PubMed Web of Science ®Google Scholar
• Litwin MS, Shpall Al, Dorey F, Nguyen TH. Quality-of-life outcomes in long-term survivors of advanced prostate cancer. Am Clin. Oncol 21(4), 327–332 (1998).
   Google Scholar
• Smith DS, Carvalhal GF, Schneider K,Krygiel J, Yan Y, Catalona WJ. Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer 88(6), 1454–1463 (2000).
   PubMed Web of Science ®Google Scholar
• Yarbro CH, Ferrans CE. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol NUTS. Forum 25(4), 685–693 (1998).
   Google Scholar
• Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res. 6(5), 385–392 (1997).
   Google Scholar
• Ware JE, Jr., Brook RII, Davies AR, Lohr KN. Choosing measures of health status for individuals in general populations.Am.Public Health 71(6), 620-625(1981).
   Google Scholar
• Fowler FJ, Jr., Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Umlogy 45 (6), 1007–1013 (1995).
   Google Scholar
• Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology56 (6), 899–905 (2000).
   PubMed Web of Science ®Google Scholar
• ••A newly validated instrument that buildsupon the Prostate Cancer Index.
   Google Scholar
• Lim AJ, Brandon AH, Fiedler J etal Quality of life: radical prostatectomy versusradiation therapy for prostate cancer. J: Ural 154(4), 1420–1425 (1995).
   PubMed Web of Science ®Google Scholar
• Braslis KG, Santa-Cruz C, Brickman AL,Soloway MS. Quality of life 12 months after radical prostatectomy. BE j UV.75(1), 48–53 (1995).
   Google Scholar
• Knight SJ, Chmiel JS, Kuzel T etalQuality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. Um/. 160(5), 1765–1769 (1998).
   Google Scholar
• Kim SP, Bennett CL, Chan C, Chmiel J,Falcone D, Knight SJ. QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology13 (6), 823–832 (1999).
   PubMed Web of Science ®Google Scholar
• Joly F, Brune D, Couette JE . Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann. 0=1 9(7), 751–757 (1998).
   Google Scholar
• Cella DF, Tulsky DS, Gray G etal The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J: Clin. Oncolll (3), 570–579 (1993).
   Google Scholar
• Esper P, Mo F, Chodak G, Sinner M, Cella D,Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Umlogy50(6), 920–928 (1997).
   Google Scholar
• •An important reference for FACT-P which is often used in studies of advanced prostate cancer.
   Google Scholar
• Lee WR, McQuellon RP, Case LD,deGuanan AF, McCullough DL. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. J. Ural 162(2), 403–406 (1999).
   Google Scholar
• Sharp LK, Knight SJ, Nadler R etalQuality of life in low income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res. 8,461–470 (1999).
   PubMed Web of Science ®Google Scholar
• Schag CA, Ganz PA, Wing DS, Sim MS,Lee JJ. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res. 3(2), 127–141 (1994).
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, Ganz PA,Leake B, Brook RII. The UCLA ProstateCancer Index: development, reliability and validity of a health-related quality of life measure. Medical Cate 36(7), 1002–1012 (1998).
   Google Scholar
• •Development paper for the Prostate Cancer Index.
   Google Scholar
• Penson DF, Stoddard ML, Pasta DJ etalThe association between socioeconomic status, health insurance coverage and quality of life in men with prostate cancer. Clin. Epidemiol 54(4), 350–358 (2001).
   Web of Science ®Google Scholar
• Davis JW, Kuban DA, Lynch DF,Schellhammer PE Quality of life after treatment for localized prostate cancer: differences based on treatment modality. Uml. 166(3), 947–952 (2001).
   Google Scholar
• Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology56 (6), 899–905 (2000).A newly validated instrument that builds upon the Prostate Cancer Index.
   Google Scholar
• Wei JT, Dunn R, Sandler H et al A Comprehensive Comparison of Health Related Quality of Life Following Contemporary Therapies for Localized Prostate Cancer. (submitted 2000).
   Google Scholar
• Borghede G, Sullivan M. Measurement ofquality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res. 5(2), 212–222 (1996).
   Google Scholar
• Shrader-Bogen CL, Kjellberg JL,Mcpherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 79(10), 1977–1986 (1997).
   PubMed Web of Science ®Google Scholar
• Dale W Campbell T, Ignacio L etal Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms. Urology53(2), 359–366 (1999).
   PubMed Web of Science ®Google Scholar
• Caffo 0, Fellin G, Graffer U, Luciani L.Assessment of quality of life after radical radiotherapy for prostate cancer. BE j Ural78(4), 557–563 (1996).
   Google Scholar
• Giesler RB, Miles BJ, Cowen ME, Kat-tan MW Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res. 9(6), 645–665 (2000).
   Google Scholar
• Potosky AL, Harlan LC, Stanford JL . Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J. Natl Cancer Inst. 91(20), 1719–1724 (1999).
   Google Scholar
• Potosky AL, Legler J, Albertsen PC . Health Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: Results From the Prostate Cancer Outcomes Study.I Natl Cancer Inst. 92(19), 1582–1592 (2000).
   PubMed Web of Science ®Google Scholar
• Stanford JL, Feng Z, Hamilton AS etal Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAIVIA 283(3), 354–360 (2000).
   PubMed Web of Science ®Google Scholar
• Albertsen PC, Aaronson NK, Muller MJ,Keller SD, Ware JE, Jr. Health-related quality of life among patients with metastatic prostate cancer. Urology49 (2), 207–216; discussion 216–217 (1997).
   Google Scholar
• Stockier MR, Osoba D, Goodwin P, Corey P, Tannock IF. Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer. j Clin. Epidemiol 51(2), 137–145 (1998).
   Google Scholar
• Litwin MS, Lubeck DP, Stoddard ML etal Quality of life before death for men with prostate cancer: results from the CaPSURE database. Ural 165(3), 871–875 (2001).
   PubMed Web of Science ®Google Scholar
• Sloan JA, Varricchio C. Quality of Life end points in prostate chemoprevention trials. Urology57(4 Suppl. 1), 235–240 (2001).
   Google Scholar
• Moinpour CM, Lovato LC, Thompson IM, Jr. etal Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning and health behaviors.J Clin. Oncol 18(9), 1942–1953 (2000).
   Google Scholar
• Moinpour CM, Lovato LC. Ensuring the quality of quality of life data: the Southwest Oncology Group experience. Statistics in Medicine 17(5-7), 641–651 (1998).
   PubMed Web of Science ®Google Scholar
• Moinpour CM, Hayden KA, Thompson IM, Feigl P, Metch B. Quality of life assessment in Southwest Oncology Group trials. Oncology 4(5), 79–84 (1989).
   Google Scholar
• Carvalhal GF, Smith DS, Ramos C . Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening. Ural 162(1), 113–118 (1999).
   PubMed Web of Science ®Google Scholar
• Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll PR. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am. j Managed Cam 6(1), 70–76 (2000).
   PubMed Web of Science ®Google Scholar
• Eton DT, Lepore SJ, Helgeson VS. Early Quality of Life in Patients with Localized Prostate Carcinoma. An examination of treatment related, demographic and pyschosocial factors. Cancer 92(6), 1451–1459 (2001).
   Google Scholar
• Litwin MS, Steinberg M, Malin J et al. Prostate Cancer Patient Outcomes and Choice of Providers: Development of an Infrastructure for Quality Assessment. A RAND Report for the Bing Fund. (2000).
   Google Scholar
• Lubeck DP, Litwin MS, Henning JM . The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology48(5), 773–777 (1996).
   Google Scholar
• Da Silva FC, Reis E, Costa T, Denis L. Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group. Cancer71 (3 Suppl.), 1138–1142 (1993).
   Google Scholar
• Davis JW, Kuban DA, Lynch DF, Schellhammer PE Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J. Ural 166(3), 947–952 (2001).
   PubMed Web of Science ®Google Scholar